Scholarly Index
Douglas W. Zochodne
University of Alberta; 16,879 total citations; 285 total publications; best world rank #14
University of Alberta
16,879Total citations
285Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pain Mechanisms and Treatments | Lifetime | 105 | CA 8 | 99.34 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 105 | CA 7 | 99.25 |
| Nerve injury and regeneration | Lifetime | 90 | CA 9 | 99.24 |
| Axon Guidance and Neuronal Signaling | Lifetime | 115 | CA 4 | 98.13 |
| Neuropeptides and Animal Physiology | Lifetime | 643 | CA 31 | 97.92 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 436 | CA 26 | 97.73 |
| Peripheral Neuropathies and Disorders | Lifetime | 520 | CA 16 | 96.13 |
| Myasthenia Gravis and Thymoma | Lifetime | 466 | CA 12 | 94.82 |
| Hereditary Neurological Disorders | Lifetime | 336 | CA 6 | 94.86 |
| Peripheral Nerve Disorders | Lifetime | 534 | CA 26 | 94.45 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 865 | CA 38 | 92.81 |
| Calpain Protease Function and Regulation | Lifetime | 299 | CA 13 | 88.92 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 14 | CA 1 | 90.97 |
| Nerve injury and regeneration | 2021-2025 | 125 | CA 3 | 90.57 |
| Hereditary Neurological Disorders | 2021-2025 | 677 | CA 16 | 62.12 |